Meeting of experts on biomarkers to discriminate bacterial from other infectious causes of acute fever

A meeting convened on 22-23 September 2015 in Geneva by WHO, ReAct, MSF Access Campaign and FIND gathered together more than 50 biomarker scientists, policymakers, implementers, clinical researchers and industry product developers. The meeting assembled a wide diversity of stakeholders representing the full “bench to bedside” pathway for biomarker testing to differentiate between bacterial and viral pathogens. Speakers and participants discussed the critical need for community-level fever diagnostics globally, reviewed initiatives that are currently underway and discussed clinically relevant performance data with the ultimate aim of improved patient care and the reduced use of antimicrobials.